Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors
- 1 May 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 330 (4) , 1205-1212
- https://doi.org/10.1016/j.bbrc.2005.03.101
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Tumor necrosis factor family ligand–receptor bindingCurrent Opinion in Structural Biology, 2004
- Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapyCytokine & Growth Factor Reviews, 2003
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- Crystal Structure of TRAIL-DR5 Complex Identifies a Critical Role of the Unique Frame Insertion in Conferring Recognition SpecificityJournal of Biological Chemistry, 2000
- Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic MutationsScience, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death DomainImmunity, 1997
- An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAILScience, 1997
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995